Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CLEAR: Bimatoprost 0.01% in Glaucoma and Ocular Hypertension
NCT01833741Phase 4Completed
- Sponsor
- Allergan
- Start
- Dec 2009
- Primary completion
- Mar 2011
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of bimatoprost in primary open-angle glaucoma (POAG), ocular hypertension, sponsored by Allergan. Started Dec 2009; status: completed.
02
Drugs
bimatoprost
03
Conditions
primary open-angle glaucoma (POAG)ocular hypertension
Beyond the preview
Go deeper on NCT01833741.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01833741.